New Age Alpha Advisors LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 423,274 shares of the pharmacy operator's stock, valued at approximately $3,949,000.
A number of other institutional investors and hedge funds also recently made changes to their positions in WBA. Brooklyn Investment Group lifted its stake in Walgreens Boots Alliance by 21.1% during the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator's stock valued at $44,000 after acquiring an additional 830 shares in the last quarter. First Financial Corp IN lifted its position in shares of Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after purchasing an additional 885 shares in the last quarter. CWA Asset Management Group LLC boosted its holdings in Walgreens Boots Alliance by 9.2% during the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator's stock worth $120,000 after purchasing an additional 1,084 shares during the last quarter. Metis Global Partners LLC grew its position in Walgreens Boots Alliance by 4.9% in the 4th quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator's stock worth $222,000 after purchasing an additional 1,118 shares in the last quarter. Finally, Harbour Investments Inc. increased its stake in Walgreens Boots Alliance by 4.3% in the 4th quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock valued at $265,000 after buying an additional 1,165 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company's stock.
Walgreens Boots Alliance Stock Performance
Shares of Walgreens Boots Alliance stock traded down $0.02 during trading hours on Monday, reaching $11.17. The company had a trading volume of 10,050,165 shares, compared to its average volume of 20,976,549. The firm has a market cap of $9.65 billion, a PE ratio of -1.09, a price-to-earnings-growth ratio of 1.31 and a beta of 0.62. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $21.74. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The business has a fifty day simple moving average of $10.83 and a 200 day simple moving average of $9.92.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter last year, the company earned $0.66 EPS. The firm's revenue was up 7.6% compared to the same quarter last year. On average, analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.
Analyst Ratings Changes
WBA has been the subject of several recent analyst reports. Evercore ISI upped their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Bank of America upped their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research note on Monday, January 13th. StockNews.com initiated coverage on Walgreens Boots Alliance in a research report on Wednesday, March 26th. They set a "hold" rating for the company. Truist Financial reduced their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Friday, January 31st. Finally, Royal Bank of Canada lifted their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a research report on Wednesday, January 15th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Walgreens Boots Alliance has a consensus rating of "Hold" and an average price target of $10.59.
Check Out Our Latest Analysis on WBA
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
